Cell Source, Inc.

CLCS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2016 FY2015 FY2014 FY2013
Assets
Cash & Equivalents $3.7K $6.9K $19.5K $28.9K
Accounts Receivable — — — —
Inventory — — — —
Total Current Assets $210.7K $213.6K $121.0K $92.2K
Property, Plant & Equipment $407 $1.3K $2.1K $0
Goodwill — — — —
Intangible Assets (Excl. Goodwill) — — — —
Total Assets $211.1K $214.8K $123.1K $92.2K
Liabilities
Accounts Payable $219.1K $119.9K $233.9K $103.7K
Total Current Liabilities $6.5M $5.9M $3.9M $789.5K
Long-Term Debt — — — —
Total Liabilities $6.5M $6.0M $3.9M $789.5K
Stockholders' Equity
Retained Earnings $-11.5M $-10.5M $-8.0M $-3.9M
Total Stockholders' Equity $-6.2M $-5.8M $-3.8M $-697.3K
← Newer Page 2 of 2 Older →